RankAlpha logo
Back to Rankings

CUE

Cue BiopharmaD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
CUE vs peer average
51/100
CUE vs. peer average (D vs. D)
Grade spread
B 2 · C 2 · F 7
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

MRKR is the first available peer comparator.

Marker Therapeutics is the closest small-cap oncology development peer in the packet because valuation is similarly driven by clinical-platform optionality, balance-sheet durability, and financing sensitivity rather than commercial revenue.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerMRKRMarker Therapeutics
CUE
Cue Biopharma
MRKR
Marker Therapeutics
Grade
D
B
Momentum
94
74
Value
41
41
Sentiment
0
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive
Open Side-by-Side ComparisonCompare all

Grade position vs MRKR

CUE / MRKR
Grade Position
In line
CUE vs. peer average (D vs. D)
51/100
Momentum
94
CUE
Value
41
CUE
Sentiment
0
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs CUE
1
MRKR
MRKR
B
80/100
-2
2
SNTI
SNTI
F
20/100
+1
3
BRNS
BRNS
F
20/100
+1
4
TLSA
Tiziana Life Sciences Ltd Common
F
20/100
+1
5
GNLX
Genelux Corp Common
F
20/100
+1
MRKR is the first peer returned for this comparison set.